Back
Reneo Pharmaceuticals Stock Predictions
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
RPHM
Reneo Pharmaceuticals
Last Price:
1.50
Seasonality Move:
-26.13%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmReneo Pharmaceuticals Stock Forecast
-
Is Reneo Pharmaceuticals Stock Undervalued?
The current Reneo Pharmaceuticals [RPHM] share price is $1.50. The Score for RPHM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal. - RPHM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Reneo Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Reneo Pharmaceuticals Stock Rating
Data Unavailable
Reneo Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
reneopharma.com
52-Week Data
52-Week High:
9.21
52-Week Low:
0.98
Prediction Charts
Market Cap:
50.14M
Price in USD:
1.50
Volume:
727.57K
Beta:
0.20
Technical Analysis
SMA50:
1.47
SMA100:
1.57
SMA200:
1.85
52-Wk Change:
-78.6%
Stock Predictions
-
Is Reneo Pharmaceuticals stock public?
Yes, Reneo Pharmaceuticals is a publicly traded company. -
What is the Reneo Pharmaceuticals stock quote today?
The Reneo Pharmaceuticals stock price is 1.50 USD today. -
How to buy Reneo Pharmaceuticals stock online?
You can buy Reneo Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 1.52 | 1.50 | 1.53 | 1.39 |
| Aug-30 | 1.47 | 1.49 | 1.58 | 1.47 |
| Sep-3 | 1.46 | 1.43 | 1.49 | 1.43 |
| Sep-4 | 1.43 | 1.43 | 1.54 | 1.43 |
| Sep-5 | 1.43 | 1.43 | 1.46 | 1.43 |
| Sep-6 | 1.46 | 1.43 | 1.47 | 1.43 |
| Sep-9 | 1.49 | 1.43 | 1.52 | 1.43 |
| Sep-10 | 1.43 | 1.42 | 1.50 | 1.42 |
| Sep-11 | 1.42 | 1.42 | 1.52 | 1.42 |
| Sep-12 | 1.34 | 1.41 | 1.42 | 1.29 |
| Sep-13 | 1.36 | 1.31 | 1.39 | 1.25 |
| Sep-16 | 1.34 | 1.37 | 1.42 | 1.31 |
| Sep-17 | 1.38 | 1.39 | 1.41 | 1.27 |
| Sep-18 | 1.35 | 1.50 | 1.57 | 1.35 |
Reneo Pharmaceuticals Earnings
Data Unavailable
Reneo Pharmaceuticals Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.04 per share.
* Reneo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.